[ScinoPharm] Announcement regarding the Board's approval to lift non-compete restrictions for managers
NQ Score
44/100
N1 Content Completeness
10
AI Summary (NQ-processed)
ScinoPharm has approved the lifting of non-compete restrictions for Chairman Luo Chih-hsien and General Manager Lu Li-an, allowing them to hold concurrent positions within the Uni-President Group's China operations. There is no financial impact on ScinoPharm.
AI Analysis
Frequently Asked Questions
- Q: Why is this disclosure required?
- A: Under Taiwan's Company Act, directors and managers must obtain board approval and disclose any concurrent positions in competing businesses to protect shareholder interests.